Loading clinical trials...
Loading clinical trials...
Phase 1 Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy
Conditions
Interventions
Clioquinol
Locations
1
Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
August 1, 2009
Primary Completion Date
September 1, 2013
Completion Date
September 1, 2013
Last Updated
June 22, 2015
NCT06285890
NCT06220162
NCT07277231
NCT05006716
NCT04065399
NCT06859424
Lead Sponsor
University Health Network, Toronto
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions